Obesity drugmaker Novo Nordisk posts strong profit
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday (Nov ...
Tag: drugmaker
Lilly’s US$2.5 billion German plant will boost obesity-drug supply
ELI Lilly kicked off construction of a new plant to boost the production of its wildly popular weight-loss drugs, which ...
China’s first biosimilar Ozempic drug applies for approval
A CHINESE drugmaker has developed a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic and applied for its approval. Hangzhou ...
Japan drugmaker reports two more deaths in supplement scare
A JAPANESE drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
NEWS
- Business
- Technology
- Entertainment
- Sports
- Lifestyle
- Health
- Politics
- Real Estate
© 2025 The New York Journals. All Rights Reserved.